Searched for
OCULAR DISEASE TREATMENT DRUG
Lupin partner Sandoz launches RanluspecTM across Europe for retinal disease treatmentLupin Ltd has partnered with Sandoz to launch RanluspecTM, a biosimilar for Ranibizumab, across Europe. This launch will help to improve ac...- India may open doors to multinational pharma firms for first-in-human Phase I trialsIndia is considering modifications to its pharmaceutical regulatory framework to attract multinational companies for clinical trials. Discu...
- Dario Amodei says AI could make cancer, Alzheimer’s ‘relics of the past’ in less than a decade as Anthropic expands AI-driven drug discovery pushAnthropic is collaborating with several pharmaceutical companies to utilize AI in drug development processes. These partnerships aim to imp...
- GLP-1 drugs for weight loss Ozempic, Wegovy linked to vision loss: What is NAION, who is at risk and what symptoms should users watch for?Side effects of weight loss drugs: The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label abou...
- Ozempic Zepbound eye risk warnings: Diabetes, weight-loss drugs Novo Nordisk's Ozempic, Wegovy, Eli Lilly's Mounjaro, Zepbound pose potential threat to eye, sudden vision loss, warns US FDAEli Lilly's Mounjaro and Zepbound and Novo Nordisk's Ozempic and Wegovy were under scanner of United States Food and Drug Administration (U...
- Over 1,300 anti-cancer drugs to get cheaperIndia's National Pharmaceutical Pricing Authority is set to cap trade margins on anti-cancer drugs starting November 2026. The initiative a...
- Joe Biden health news: How serious is the ex-President's prostrate cancer as he says he will limit promoting his memoir 'Promise me America'Joe Biden has provided a health update about his prostate cancer treatment as he prepares his memoir. His son, Hunter Biden, described the ...
- Cancer drug prices revised from today; patients may save Rs 3,540 crore annuallyThe government has revised the prices of 1,364 anti-cancer medicine formulations effective from November 9. This decision aims to limit tra...
- Healthcare needs stronger partnerships between hospitals and insurersAditya Birla Health Insurance CEO and Manipal Hospitals MD-CEO argue that India's healthcare system must move beyond transactional relation...
- 'Liquid biopsy can ease financial burden for cancer patients': Scientists on how a $1,000 test could save $10,000 in treatment costsLiquid biopsy, a blood-based test that detects and analyses cancer-related biomarkers, is gaining ground as a tool to monitor disease progr...
- Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annuallyStarting November 9, consumers in India will benefit from significantly reduced prices on 137 anti-cancer drugs. The government has capped ...
- Pharma industry steps up API investments to cut import dependence, move up value chainIndia's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Invest...
- Scientists gave mice an existing asthma drug before exposing them to peanut extract; 95% were protected from severe allergic reactions in the experimentResearchers at Northwestern University found that the asthma drug Zileuton reduces allergic reactions in mice fed peanut extract. The study...
- Dr Reddy's Laboratories receives ANVISA approval for generic semaglutide injection in BrazilDr Reddy’s Laboratories obtained marketing authorisation from Brazil’s ANVISA for a generic semaglutide injection. The product will be avai...
- Sirolimus-coated balloon shows 8-percentage-point advantage in three-year peripheral artery trialPatients treated with sirolimus-coated balloons were more likely to remain free from repeat procedures to reopen blocked leg arteries than ...
- Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...
- His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccinesHyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technol...
- High Court restrains NPPA from action against AstraZenecaThe Delhi High Court has issued a temporary restraining order against the NPPA's actions toward AstraZeneca Pharma. This order remains in e...
- AI is no longer just coding or generating images. It has now designed a virus that was used on a human being. Did the patient survive?A California startup has used artificial intelligence to design a virus that was administered to a human patient for the first time. The ex...
- India’s drug pricing policy must balance affordability, medicine availability and pharma industry growthThe Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...
Load More
